- Home
- HQY vs ELAN Comparison
HQY vs ELAN Comparison
Compare HQY & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQY
- ELAN
- Stock Information
- Founded
- HQY 2002
- ELAN 1954
- Country
- HQY United States
- ELAN United States
- Employees
- HQY N/A
- ELAN N/A
- Industry
- HQY Business Services
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- HQY Consumer Discretionary
- ELAN Health Care
- Exchange
- HQY Nasdaq
- ELAN Nasdaq
- Market Cap
- HQY 7.9B
- ELAN 7.2B
- IPO Year
- HQY 2014
- ELAN 2018
- Fundamental
- Price
- HQY $92.28
- ELAN $18.45
- Analyst Decision
- HQY Strong Buy
- ELAN Buy
- Analyst Count
- HQY 15
- ELAN 7
- Target Price
- HQY $118.60
- ELAN $17.33
- AVG Volume (30 Days)
- HQY 1.2M
- ELAN 10.2M
- Earning Date
- HQY 09-02-2025
- ELAN 11-06-2025
- Dividend Yield
- HQY N/A
- ELAN N/A
- EPS Growth
- HQY 37.24
- ELAN N/A
- EPS
- HQY 1.65
- ELAN 0.88
- Revenue
- HQY $1,268,928,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- HQY $9.69
- ELAN $5.65
- Revenue Next Year
- HQY $8.89
- ELAN $4.97
- P/E Ratio
- HQY $56.47
- ELAN $21.07
- Revenue Growth
- HQY 15.45
- ELAN N/A
- 52 Week Low
- HQY $74.07
- ELAN $8.02
- 52 Week High
- HQY $116.65
- ELAN $19.08
- Technical
- Relative Strength Index (RSI)
- HQY 50.25
- ELAN 58.65
- Support Level
- HQY $90.07
- ELAN $18.22
- Resistance Level
- HQY $93.91
- ELAN $19.08
- Average True Range (ATR)
- HQY 2.67
- ELAN 0.55
- MACD
- HQY 0.27
- ELAN -0.09
- Stochastic Oscillator
- HQY 47.34
- ELAN 67.77
About HQY HealthEquity Inc.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.